Inactive Instrument

All News Ibio Inc Nyse

Equities

US4510331048

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

IBio Closes Sale of Manufacturing Facility in Texas	06-03	AQ
Texas A&M University System Board of Regents acquired Manufacturing facility located in Bryan, Texas of iBio, Inc. for $8.5 million.	06-02	CI
Chardan Research Starts iBio With Buy Rating, $5 Price Target	05-28	MT
IBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-13	CI
Ibio, Inc. Appoints Dr. Martin Brenner, to the Board of Directors, Effective June 1, 2024	05-13	CI
IBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update	05-13	AQ
IBio, Inc. announced that it has received $15.066157 million in funding from ADAR1 Capital Management, LLC, Lynx1 Capital Management LP, Ikarian Capital, LLC and other investors	03-31	CI
Top Premarket Gainers	03-28	MT
Top Midday Gainers	03-27	MT
Wall Street Set to Open Higher Wednesday as Investors Eye End-of-Week Economic, Inflation Data	03-27	MT
Transcript : IBio, Inc. - Special Call	03-27
US Futures Trend Higher Wednesday Pre-Bell as Investors Eye Impending Economic, Inflation Data Readings	03-27	MT
Top Premarket Gainers	03-27	MT
IBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases	03-27	AQ
IBio, Inc. and AstralBio, Inc. Announce Transformative AI Drug Discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases	03-27	CI
IBio Announces $15.0 Million Private Placement	03-26	AQ
IBio, Inc. announced that it has received $14 million in funding	03-25	CI
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	02-26	DJ
IBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka	02-26	AQ
Otsuka Pharmaceutical Co., Ltd. completed the acquisition of Preclinical PD-1 Agonist Antibody Program of iBio, Inc..	02-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Ibio Inc Nyse

Equities

US4510331048

All News

Filters